EVLV — Evolv Technologies Holdings, Inc.

Summary of Evolv Technology (EVLV) Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 Revenue: $38.5 million, up 32% year-over-year.
• Full Year Revenue: $145.9 million, reflecting a 40% increase year-over-year.
• Annual Recurring Revenue (ARR): $120.5 million at year-end, a 21% increase year-over-year.
• Adjusted EBITDA: Positive $1.8 million in Q4, with a margin of 4.7%; full-year adjusted EBITDA was $11.1 million, up from a loss of $21 million in 2024.
• Remaining Performance Obligation (RPO): $293.4 million, a 13% increase year-over-year.
• Cash Position: Increased by $12.8 million sequentially to $69 million, indicating strong cash collection and working capital management.

2. Strategic Updates and Business Highlights

• Customer Growth: Added over 60 new customers in Q4, totaling over 1,200 globally; strong adoption of the Gen2 Express platform.
• Market Expansion: Continued penetration in education, healthcare, and sports sectors, with notable partnerships including the American Hospital Association.
• Product Innovation: Successful launch of eXpedite, an autonomous AI-based bag screening solution, with 65 customers adopting it.
• Operational Improvements: Transitioned to a direct fulfillment model for purchase subscriptions, expected to enhance long-term revenue and gross profit despite initial margin pressures.

3. Forward Guidance and Outlook

• 2026 Revenue Guidance: Expected between $172 million to $178 million, an increase from prior guidance of $160 million to $165 million.
• ARR Growth: Anticipated to be in the range of 20% to 25% year-over-year.
• Adjusted EBITDA Margins: Expected to expand into the high single digits.
• Deployment Goals: Projecting over 10,000 units deployed by the end of 2026.

4. Bad News, Challenges, or Points of Concern

• Gross Margin Pressure: Adjusted gross margin decreased to 50% in Q4 from 62% year-over-year, impacted by the shift to direct fulfillment and a $1 million accrual for service costs.
• Subscription Revenue Fluctuations: Subscription revenue was slightly lower due to timing issues with a short-term contract related to a major sporting event.
• Market Risks: The competitive landscape remains challenging, particularly with the rise of generative AI and potential disruptions in the software sector.

5. Notable Q&A Insights

• Customer Mix: Approximately 50% of bookings came from new customers, with the same expected for 2026.
• Cash Flow Expectations: While Q4 showed strong cash generation, the first half of 2026 may see pressures from prior year incentive payments. Overall, cash flow is expected to improve in the second half of 2026.
• Plexus Partnership: Production from the Plexus relationship is expected to ramp up in the second half of 2026, potentially benefiting gross margins and working capital.
• Healthcare Growth: The partnership with the American Hospital Association is anticipated to accelerate hospital deals, supported by regulatory trends mandating weapon screening in schools and healthcare environments.

This summary encapsulates the key takeaways from Evolv Technology's Q4 2025 earnings call, highlighting both the positive developments and challenges faced by the company as it navigates a complex security landscape.